cyclic adp-ribose has been researched along with Nerve Degeneration in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Avizonis, D; Bergholz, JS; Chen, CY; de Sá Tavares Russo, M; DiAntonio, A; Hsueh, YP; Jiang, T; Ko, KW; Li, Y; Milbrandt, J; Pazyra-Murphy, MF; Segal, RA; Tang, S; Zhao, JJ; Zhu, J | 1 |
Bosanac, T; Devraj, R; DiAntonio, A; Engber, TM; Figley, MD; Hughes, RO; Krauss, R; Milbrandt, J; Sasaki, Y; Wu, T | 1 |
Hu, S; Peterson, PK; Shideman, CR; Thayer, SA | 1 |
3 other study(ies) available for cyclic adp-ribose and Nerve Degeneration
Article | Year |
---|---|
Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPN.
Topics: Animals; Armadillo Domain Proteins; Axons; Calcium; Calcium Channels; Cyclic ADP-Ribose; Cytoskeletal Proteins; Female; HEK293 Cells; Humans; Mice, Inbred C57BL; Nerve Degeneration; Paclitaxel; Peripheral Nervous System Diseases; Rats, Sprague-Dawley | 2022 |
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Topics: Animals; Armadillo Domain Proteins; Axons; Biomarkers; Brain; Cells, Cultured; Cyclic ADP-Ribose; Cytoskeletal Proteins; Gene Dosage; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Sciatic Nerve | 2020 |
CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism.
Topics: Agammaglobulinaemia Tyrosine Kinase; Calcium; Calcium Channels; Calcium Signaling; Cells, Cultured; Chemokine CCL5; Chemokines, CC; Cyclic ADP-Ribose; Encephalitis; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Immunity, Innate; Immunologic Surveillance; Inositol 1,4,5-Trisphosphate; Janus Kinase 1; Microglia; NAD; Nerve Degeneration; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Receptors, CCR5; Signal Transduction; Type C Phospholipases | 2006 |